Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Hancock

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: views of the younger adultK Absolom, C Eiser, G Michel, et al.
Histopathology|June 26, 2001
Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancyJ L Burton, E A Lidbury, A M Gillespie, et al.
British Journal of Cancer|April 1, 1991
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term resultsB W Hancock, G Vaughan Hudson, B Vaughan Hudson, et al.
Gynecologic Oncology|March 10, 2009
Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasiaL M El-Helw, R E Coleman, J E Everard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2009
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)W S Owadally, M R Sydes, J A Radford, et al.
International Journal of Oncology|April 17, 2002
The incidence of thyroid abnormalities in adults irradiated for lymphomaS H Ding, S D Pledge, B J Harrison, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2004
The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patientsN Bhala, J M Coleman, C R Radstone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trialB W Hancock, G Vaughan Hudson, B Vaughan Hudson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatantsC A McIntyre, K Chapman, S Reeder, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: views of the younger adultK Absolom, C Eiser, G Michel, et al.
Histopathology|June 26, 2001
Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancyJ L Burton, E A Lidbury, A M Gillespie, et al.
British Journal of Cancer|April 1, 1991
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term resultsB W Hancock, G Vaughan Hudson, B Vaughan Hudson, et al.
Gynecologic Oncology|March 10, 2009
Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasiaL M El-Helw, R E Coleman, J E Everard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2009
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)W S Owadally, M R Sydes, J A Radford, et al.
International Journal of Oncology|April 17, 2002
The incidence of thyroid abnormalities in adults irradiated for lymphomaS H Ding, S D Pledge, B J Harrison, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2004
The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patientsN Bhala, J M Coleman, C R Radstone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trialB W Hancock, G Vaughan Hudson, B Vaughan Hudson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatantsC A McIntyre, K Chapman, S Reeder, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
Pageof 15